Steffen Teller
YOU?
Author Swipe
View article: Phenotype screens of murine pancreatic cancer identify a Tgf-α-Ccl2-paxillin axis driving human-like neural invasion
Phenotype screens of murine pancreatic cancer identify a Tgf-α-Ccl2-paxillin axis driving human-like neural invasion Open
Solid cancers like pancreatic ductal adenocarcinoma (PDAC), a type of pancreatic cancer, frequently exploit nerves for rapid dissemination. This neural invasion (NI) is an independent prognostic factor in PDAC, but insufficiently modeled i…
View article: Supplementary figure legends from Neoadjuvant Therapy Remodels the Pancreatic Cancer Microenvironment via Depletion of Protumorigenic Immune Cells
Supplementary figure legends from Neoadjuvant Therapy Remodels the Pancreatic Cancer Microenvironment via Depletion of Protumorigenic Immune Cells Open
Supplementary figure legends
View article: Data from Neoadjuvant Therapy Remodels the Pancreatic Cancer Microenvironment via Depletion of Protumorigenic Immune Cells
Data from Neoadjuvant Therapy Remodels the Pancreatic Cancer Microenvironment via Depletion of Protumorigenic Immune Cells Open
Purpose:Neoadjuvant therapy (neoTx) has dramatically improved the prognosis of patients with locally advanced and borderline resectable pancreatic ductal adenocarcinoma, yet its mechanisms of action on tumor cells and the tumor microenviro…
View article: Supplementary figure legends from Neoadjuvant Therapy Remodels the Pancreatic Cancer Microenvironment via Depletion of Protumorigenic Immune Cells
Supplementary figure legends from Neoadjuvant Therapy Remodels the Pancreatic Cancer Microenvironment via Depletion of Protumorigenic Immune Cells Open
Supplementary figure legends
View article: Supplementary figures from Neoadjuvant Therapy Remodels the Pancreatic Cancer Microenvironment via Depletion of Protumorigenic Immune Cells
Supplementary figures from Neoadjuvant Therapy Remodels the Pancreatic Cancer Microenvironment via Depletion of Protumorigenic Immune Cells Open
Supplementary Figure 1. Object-based automated detection analysis of immune cell infiltration in human PCa with CellProfiler Software. Supplementary Figure 2. Automated analysis of the angiogenesis and stromal activation in PCa. Supplement…
View article: Supplementary figures from Neoadjuvant Therapy Remodels the Pancreatic Cancer Microenvironment via Depletion of Protumorigenic Immune Cells
Supplementary figures from Neoadjuvant Therapy Remodels the Pancreatic Cancer Microenvironment via Depletion of Protumorigenic Immune Cells Open
Supplementary Figure 1. Object-based automated detection analysis of immune cell infiltration in human PCa with CellProfiler Software. Supplementary Figure 2. Automated analysis of the angiogenesis and stromal activation in PCa. Supplement…
View article: Supplementary tables 1-5 from Neoadjuvant Therapy Remodels the Pancreatic Cancer Microenvironment via Depletion of Protumorigenic Immune Cells
Supplementary tables 1-5 from Neoadjuvant Therapy Remodels the Pancreatic Cancer Microenvironment via Depletion of Protumorigenic Immune Cells Open
Supplementary Table 1. Clinical characteristics of neoadjuvantly treated vs upfront resected PDAC patients and the types of neoadjuvant regimens. Supplementary Table 2. Specifications and dilutions of the primary antibodies used in our exp…
View article: Data from Neoadjuvant Therapy Remodels the Pancreatic Cancer Microenvironment via Depletion of Protumorigenic Immune Cells
Data from Neoadjuvant Therapy Remodels the Pancreatic Cancer Microenvironment via Depletion of Protumorigenic Immune Cells Open
Purpose:Neoadjuvant therapy (neoTx) has dramatically improved the prognosis of patients with locally advanced and borderline resectable pancreatic ductal adenocarcinoma, yet its mechanisms of action on tumor cells and the tumor microenviro…
View article: Supplementary tables 1-5 from Neoadjuvant Therapy Remodels the Pancreatic Cancer Microenvironment via Depletion of Protumorigenic Immune Cells
Supplementary tables 1-5 from Neoadjuvant Therapy Remodels the Pancreatic Cancer Microenvironment via Depletion of Protumorigenic Immune Cells Open
Supplementary Table 1. Clinical characteristics of neoadjuvantly treated vs upfront resected PDAC patients and the types of neoadjuvant regimens. Supplementary Table 2. Specifications and dilutions of the primary antibodies used in our exp…
View article: One‐Year Landmark Analysis of the Effect of Beta‐Blocker Dose on Survival After Acute Myocardial Infarction
One‐Year Landmark Analysis of the Effect of Beta‐Blocker Dose on Survival After Acute Myocardial Infarction Open
Background Although beta‐blockers are recommended following myocardial infarction (MI), the benefits of long‐term treatment have not been established. The study's aim was to evaluate beta‐blocker efficacy by dose in 1‐year post‐MI survivor…
View article: Indirect cholinergic activation slows down pancreatic cancer growth and tumor-associated inflammation
Indirect cholinergic activation slows down pancreatic cancer growth and tumor-associated inflammation Open
Background: Nerve-cancer interactions are increasingly recognized to be of paramount importance for the emergence and progression of pancreatic cancer (PCa). Here, we investigated the role of indirect cholinergic activation on PCa progress…
View article: Indirect cholinergic activation slows down pancreatic cancer growth and tumor-associated inflammation
Indirect cholinergic activation slows down pancreatic cancer growth and tumor-associated inflammation Open
View article: Mesenchymal Plasticity Regulated by Prrx1 Drives Aggressive Pancreatic Cancer Biology
Mesenchymal Plasticity Regulated by Prrx1 Drives Aggressive Pancreatic Cancer Biology Open
View article: Indirect cholinergic activation slows down pancreatic cancer growth and tumor-associated inflammation
Indirect cholinergic activation slows down pancreatic cancer growth and tumor-associated inflammation Open
Background Nerve-cancer interactions are increasingly recognized to be of paramount importance for the emergence and progression of pancreatic cancer (PCa). Here, we investigated the role of indirect cholinergic activation on PCa progressi…
View article: Localisation analysis of nerves in the mouse pancreas reveals the sites of highest nerve density and nociceptive innervation
Localisation analysis of nerves in the mouse pancreas reveals the sites of highest nerve density and nociceptive innervation Open
Background Neuropathy and neuro‐inflammation drive the severe pain and disease progression in human chronic pancreatitis and pancreatic cancer. Mice, especially genetically induced‐mouse models, have been increasingly utilized in mechanist…
View article: Neoadjuvant Therapy Remodels the Pancreatic Cancer Microenvironment via Depletion of Protumorigenic Immune Cells
Neoadjuvant Therapy Remodels the Pancreatic Cancer Microenvironment via Depletion of Protumorigenic Immune Cells Open
Purpose: Neoadjuvant therapy (neoTx) has dramatically improved the prognosis of patients with locally advanced and borderline resectable pancreatic ductal adenocarcinoma, yet its mechanisms of action on tumor cells and the tumor microenvir…
View article: Targeting nNOS ameliorates the severe neuropathic pain due to chronic pancreatitis
Targeting nNOS ameliorates the severe neuropathic pain due to chronic pancreatitis Open
View article: Early pancreatic cancer lesions suppress pain through CXCL12-mediated chemoattraction of Schwann cells
Early pancreatic cancer lesions suppress pain through CXCL12-mediated chemoattraction of Schwann cells Open
Significance Pancreatic ductal adenocarcinoma cancer (PDAC) cells have an exceptional propensity to invade nerves via pronounced crosstalk between nerves and cancer cells, but the mechanisms of this early neural invasion are yet unknown. B…
View article: Tumour-specific delivery of siRNA-coupled superparamagnetic iron oxide nanoparticles, targeted against PLK1, stops progression of pancreatic cancer
Tumour-specific delivery of siRNA-coupled superparamagnetic iron oxide nanoparticles, targeted against PLK1, stops progression of pancreatic cancer Open
Our data suggest siPLK1-StAv-SPIONs with dual specificity residues for tumour targeting and membrane translocation to represent an exciting opportunity for targeted therapy in patients with PDAC.
View article: Neurogenesis and angiogenesis in pancreatic cancer evolve concordantly via distinct transcriptional profiles
Neurogenesis and angiogenesis in pancreatic cancer evolve concordantly via distinct transcriptional profiles Open
View article: Activated Schwann cells in pancreatic cancer are linked to analgesia via suppression of spinal astroglia and microglia
Activated Schwann cells in pancreatic cancer are linked to analgesia via suppression of spinal astroglia and microglia Open
Objective The impact of glia cells during GI carcinogenesis and in cancer pain is unknown. Here, we demonstrate a novel mechanism how Schwann cells (SCs) become activated in the pancreatic cancer (PCa) microenvironment and influence spinal…